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Objective: Cartilage repair elicited by bone marrow stimulation can be enhanced by a chitosan-glycerol
phosphate (GP)/blood implant, through mechanisms involving therapeutic inﬂammatory angiogenesis.
The implant is formed by in situ coagulation, which can be accelerated by adding coagulation factors. We
hypothesized that coagulation factors enhance acute subchondral angiogenesis in repairing drilled
defects.
Design: Full-thickness cartilage defects were created bilaterally in 12 skeletally mature rabbit knee
trochlea, microdrilled, then allowed to bleed as a control (N ¼ 6) or treated with chitosan-GP/blood
implant (N ¼ 6), or implant solidiﬁed with thrombin (IIa), tissue factor (TF) with recombinant human
factor VIIa (rhFVIIa), or rhFVIIa alone (N ¼ 4 each condition). At 3 weeks post-operative, quantitative
stereology was used to obtain blood vessel length (LV), surface (SV), and volume (VV) density at systematic
depths in two microdrill holes per defect. Collagen type I, type II and glycosaminoglycan (GAG) percent
stain in non-mineralized repair tissue were analysed by histomorphometry.
Results: All drill holes were healing, and showed a depth-dependent increase in granulation tissue blood
vessel density (Lv, Sv, and Vv, P < 0.005). Residual chitosan implant locally suppressed blood vessel
ingrowth into the granulation tissue, whereas holes completely cleared of chitosan ampliﬁed angio-
genesis vs microdrill-only (P ¼ 0.049), an effect enhanced by IIa. Chitosan implant suppressed strong Col-
I, Col-II, and GAG accumulation that occurred spontaneously in drill-only bone defects (P < 0.005) and
coagulation factors did not alter this effect.
Conclusions: Subchondral angiogenesis is promoted by chitosan implant clearance. Chitosan implant
treatment suppresses ﬁbrocartilage scar tissue formation, and promotes bone remodeling, which allows
more blood vessel migration and woven bone repair towards the cartilage lesion area.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
In wound repair, damaged tissue becomes inﬁltrated with a
blood clot scaffold that supports the ingrowth of immune cells and
progenitor cells for the next stages of inﬂammation: granulation
tissue formation, angiogenesis, and remodeling, followed by new
tissue formation (reviewed in1,2). Bone marrow stimulation tech-
niques for articular cartilage repair, such as microfracture and
microdrilling, have been developed to create access channels be-
tween the cartilage lesion and subchondral bone cells3e5..D. Hoemann, Department of
6079, Station Centre-Ville,
Fax: 1-514-340-2980.
. Hoemann).
s Research Society International. PResidency and adhesion of the blood clot to bone at the base of the
cartilage lesion is believed to be an important factor for good
repair5. To improve the wound repair response to marrow stimu-
lation, a stabilized blood clot implant was previously developed
using a mixture of liquid chitosan, glycerol phosphate (GP) and
autologous blood (chitosan-GP/blood)6e8. The mixture gels and
clots in situ over the microfracture holes, adheres better to the
defect, and elicits a more hyaline repair thanmicrofracture-alone in
animal models6. The beneﬁcial effects of the chitosan/blood
implant were previously tied to increased subchondral angiogen-
esis at the early stages of microfracture repair7e9, but the role of
early angiogenesis is still not fully understood.
Angiogenesis is the growth of new blood vessels (BVs) from
existing vessels10. Acute angiogenesis is commonly required for
tissue regeneration and repair, since stem cells and stromal cellsublished by Elsevier Ltd. All rights reserved.
Table I
Experimental design of the in vivo cartilage repair study 21 days post-operative in
NZW Rabbits
Group* Number of animalsy Treated knee Control knee
1 Female, N ¼ 2;
Male, N ¼ 2
Implant with
rhFVIIax
Chitosan-GP/blood
implant-only
2az Female, N ¼ 1;
Male N ¼ 1
Implant with
TF þ rhFVIIak
Chitosan-GP/blood
implant-only
2b Female, N ¼ 1;
Male, N ¼ 1
Implant with
TF þ rhFVIIak
Drilled defect only
3 Female, N ¼ 3;
Male, N ¼ 1
Implant with
thrombin{
Drilled defect only
* Groups 1 and 2a used implant “mini-kits” (500 mL chitosan-GP þ 1.5 mL whole
blood) due to bilateral implant treatment, while groups 2b and 3 used the implant
volume employed in the clinic (1.5 mL chitosan-GP þ 4.5 mL whole blood) and
unilateral implant treatment.
y Alternating left-right full-thickness cartilage defects were treated as follows:
N¼ 6 drill-only, or drilling with N¼ 6 implant, or N¼ 4 implantþ coagulation factor
(rhFVIIa, TFþrhFVIIa, or thrombin).
z This group originally had N ¼ 2 females but 1 had an unscheduled death at 13
days post-op and was removed from the analysis, leaving N ¼ 1 female.
x 10 mg/mL (200 nM) rhFVIIa pre-mixed with whole blood prior to combining
with chitosan-GP.
k 3 mL of a mixture of 500 ng/mL TFþ 5 mg/mL (100 nM) rhFVIIa pre-loaded on the
drill defect prior to applying chitosan-GP, w60s delay.
{ 3 mL of 15 or 45 U/mL thrombin pre-loaded on the drill defect prior to applying
chitosan-GP, w60s delay.
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and survive10,11. In a subchondral bone wound, granulation tissue
will form along with the spontaneous appearance of chondrogenic
foci12,13. When chondrogenic foci arise in the trabecular bone, they
form a callus that proceeds to ossify into endochondral bone. When
they arise at the level of the bone plate, chondrogenic foci are the
precursor structures of hyaline articular cartilage repair8,9,12,13.
Because woven bone repair is promoted by angiogenesis9, treat-
ments that stimulate acute angiogenesis in a bone marrow stimu-
lation defect may help displace the formation of chondrogenic foci
to the bone plate area12, and improve the osteochondral cartilage
repair response.
Coagulation factors are known to promote angiogenesis, cell
chemotaxis and cell proliferation in vitro14e17. Furthermore,
thrombin (IIa), tissue factor (TF), and recombinant human factor
VIIa (rhFVIIa) were shown to accelerate in situ coagulation of the
chitosan-GP/blood implant over microdrilled cartilage defects in a
rabbit cartilage repair model18. However the effect of coagulation
factors on early angiogenesis in marrow stimulation repair is un-
known. The purpose of this study was to investigate the inﬂuence
of coagulation factors and chitosan-GP/blood implant, in early
osteochondral repair. We tested the hypothesis that coagulation
factors increase chitosan-based angiogenesis at 3 weeks post-
operative in rabbit microdrill holes, when drill-only holes are
starting to form subchondral chondrogenic foci, and chitosan-
treated holes are still in the angiogenic phase8.
Another goal of this study was to use stereology measures to
elucidate angiogenesis mechanisms in subchondral drill holes.
Stereology is a mathematical method to estimate densities of 3D
structures in a matrix with only its 2D representation8,19e21. The
referential matrix in this case, consists in microscopic drill hole
granulation tissue images in histological sections19,21e23, from
which one may analyse BV length density (LV, mm length of vessels
per mm3 ﬁeld), surface density (SV, mm2 vessel perimeter per mm3
ﬁeld, or per mm3 BV) and volume density (VV, mm3 area of vessels
per mm3 ﬁeld). To account for an anisotropic shape of the repairing
drill hole, a depth-wise sampling of the repair tissue in the middle
of each hole was used to analyse the ingrowth of BVs into the
repairing bone defect.
Materials and methods
Materials and implant generation
Puriﬁed human IIa (T4393, SigmaeAldrich, ON, Canada), was
reconstituted at 100 U/mL, stored as frozen aliquots and diluted to
15 or 45 U/mL the day of surgery, TF (Innovin, Product No. B4212-
50, Dade/Cedarlane, Mississauga, ON, Canada), was reconstituted in
2cc sterile Water For Injection, WFI, and rhFVIIa (Novonordisk,
Copenhagen, Denmark) was reconstituted in WFI at 500 mg/mL and
stored at 80 C until the day of surgery. TF with rhFVIIa was
prepared by mixing 100 mL Innovin with 5 mL 500 mg/mL rhFVIIa.
Sterile 500 mM disodium b-GP/50 mM HCl pH 7.1 (GP: Lots
CG5790601A1, CG5790606A) and certiﬁed autoclave-sterile 2.1%w/
w chitosan-HCl solutions (pH 6.0, 81.0% and 81.7% DDA chitosan,
dynamic viscosity 1,100e1,410 mPa-s, medical-grade, Lots
CG3020602B, CG3020603A, CG3020612A) were from Biosyntech,
Laval QC, Canada, now Piramal Healthcare, Laval QC, Canada.
Chitosan-GP solutions were prepared in a sterile vial containing
three or six depyrogenized stainless steel mixing beads the day of
surgery, by combining 0.4 mL chitosan-HCl and 0.1 mL GP (“mini-
kit”, for rabbits with bilateral implant treatment, see Groups 1 and
2a, Table I), or 1.2 mL chitosan and 0.3 mL GP. Mini-kits were used
for bilateral implants to minimize intra-operative whole blood
collected from the rabbit. After trochlear defects were drilled,sterile autologous whole rabbit blood drawn intra-operatively for
each implant was mixed at a 3:1 v/v ratio with chitosan-GP by
manual shaking for 10 s, as described18.
In vivo articular bone marrow stimulation rabbit model
All protocols involving animals were approved by institutional
ethics committees, and analysed ﬁve test conditions in four groups
of skeletally mature animals (12 New Zealand White rabbit retired
breeders, up to 24 months old and one 7 month-old naive spare,
4.5  0.7 kg, male and female, Table I). During the study, one rabbit
(a female retired breeder w24 months old) had an unscheduled
death at 13 days post-operatively. Macroscopic necropsy did not
reveal any anatomical cause for death. Histopathology of kidney, GI
tract, liver, spleen, and lung was reviewed by an independent
pathologist at Université de Montréal, who concluded that he could
not identify any microscopic ﬁnding that could explain the death of
the animal. This rabbit was replaced by the spare rabbit, for N ¼ 12
rabbits total (see Table I). As previously described18, rabbits were
anesthetized and given small knee arthrotomies one at a time, to
create bilateral 3.5 mm 4 mm full-thickness cartilage defects that
were microdrilled (six 0.5 mm proximal, two 0.9 mm diameter
distal hole bone defects), then left to bleed (controls, N ¼ 6) or
treated by in situ coagulation of w25 mL liquid chitosan-GP/blood
implant over the drill defect (N ¼ 6) or applied in combination
with a coagulation factor pre-applied to the defect surface [3 mL IIa,
N ¼ 4, Fig. 1(C)], (3 mL InnovinþrhFVIIa, N ¼ 4), or chitosan-GP
combined with whole blood containing 200 nM rhFVIIa (N ¼ 4)19
(see Table I). Knees were closed in three sutured layers, bupre-
norphine administered for 3 days (post-operative pain manage-
ment) and rabbits allowed immediate unrestrained cage activity. At
21 days post-operative rabbits were euthanized under anaesthesia.
All knee joints were veriﬁed as free of exudates or infection at
necropsy.
Histology
Femur ends were ﬁxed in 4% paraformaldehyde/0.1% glutaral-
dehyde/100 mM cacodylate pH 7.2, decalciﬁed in 0.5 N HCl/0.1%
Fig. 1. Articular cartilage repair model before and after coagulation factor-enhanced implant delivery. In this example, (A) a full-thickness cartilage defect was created in the rabbit
knee trochlea by debriding into the calciﬁed layer, after which (B) microdrill holes (6 proximal 0.5 mm diameter, and 2 distal 0.9 mm diameter) were created under constant
irrigation with isotonic saline and ﬁnally (C) a IIa-chitosan-GP/blood implant was added and solidiﬁed over the microdrilled defect.
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through the defect, equilibrated in sucrose, and embedded in
Tissue-Tek OCT compound (Cedarlane, Hornby, ON, Canada). After
generating the histological cryosections, it was discovered that the
small proximal holes were only partly captured in many sections.
Thus only cryosections collected through the middle of the two
0.9 mm drill holes were used (Fig. 1). Immunohistochemistry was
performed with anti-collagen type I monoclonal I-8H5 (MAB6616,
Abnova, Walnut, CA, USA) and anti-collagen type II monoclonal II-
II6B3 (Developmental Studies Hybridoma Bank, DSHB, Iowa, USA),
with biotinylated anti-mouse secondary antibody and ABC-AP red
substrate detection (Vector/Cedarlane, Mississauga, ON, Canada)
and light haematoxylin counterstain. Sections were also stained
with Safranin O/fast green/Weigert iron haematoxylin and Gomori
Trichrome24.
BV stereology
Gomori-stained slides were blinded and 40 magniﬁcation
digital images were systematically acquired at up to four speciﬁc
depths in the middle of each drill hole using a calibrated histo-
morphometric software (Northern Eclipse, Empix, Mississauga,
ON, Canada). The drill hole edges and central axis were deﬁned for
each hole. Top-down measures used the surface of the granulation
tissue as a reference line [Fig. 2(A), left schematic], to acquire
images at 0.0 mm, 0.5 mm, 1.0 mm and 1.5 mm deep, excluding
images that occurred in bone. This Top-down method slightly dif-
fers from a previous study where the projected tidemark was the
top reference line and images were acquired at 0.5, 1.25 and
2.0 mmwithin the drill hole towards the bone8. Because most BVs
were observed at the base of the repairing microdrill holes, a
second method was tested: Bottom-up, which places the reference
line at the base of the hole [Fig. 2(A), right schematic], and acquires
images at 100 mm from the bottom, and at 0.5 mm intervals
towards the surface [i.e., at 0.1, 0.6, 1.1, 1.6 mm, Fig. 2(A)].
BV were scored when at least a few erythrocytes were present and
enclosed in a deﬁned structure of endothelial cells. Infrequent
vessel structures missing erythrocytes were not taken in consid-
eration (<2% of the total vessels scored), nor were clusters of
erythrocytes clearly dissociated from endothelial cells. To quantify
LV (mm/mm3; vessels/mm2), the number of BV cross-sections(QBV) in the image was counted, excluding vessels that crossed
the two “forbidden lines”, in a total image area of 0.041 mm2
[Fig. 2(B)], then the equation LV ¼ 2*QBV/(total area)19,22 was
applied. For VV (mm3/mm3), a 5.97 mm  5.97 mm grid with 1,200
total points (PT) was applied on each image. All points (grid
intersections) overlapping the BV (PBV) were counted to obtain
VV ¼ PBV/PT19,22[Fig. 2(C)]. For BV surface density, SV (mm2/mm3;
surface/mm) two approaches were used: Castello’s method (SVC),
where the granulation tissue matrix is the reference volume23, and
Grifﬁth’s method (SVG), where the BV volume is the reference
volume19. For SV, a grid with 30 horizontal lines, 0.233 mm long
at 5.97 mm spacing was randomly placed on the image [Fig. 2(D)],
and all intersections between the lines and the BV endothelial
cell perimeter were quantiﬁed (IBV). Since a horizontal line
grid is used, the IBV is multiplied by 2 (2*IBV). Therefore
SVC¼ 2*IBV/(total length)23, with granulation tissue represented by
total length ¼ 0.233 mm  30, the number of grid lines. SVG
(mm2 BV/mm3 BV) employs the same 2*IBV value but divided by all
points inside of BVs (PBV) times the distance between grid points
(d) [Fig. 2(C)], and SVG ¼ 2*IBV/(d*PBV)19. Note that the average SVG
per hole was calculated strictly from ﬁelds that contained at least
one BV, which resulted in missing values for some Top-down
measures with no BVs at the surface [square 1, Fig. 2(A)].
Histomorphometric analysis of repair tissue collagen type II,
collagen type I and GAG content
Blinded sections were used to analyse drill hole soft tissue cross-
sectional area and percent Safranin O (SafO), Collagen type I (Col-I)
and type II (Col-II) staining by threshold analysis with the HSV color
system7. Soft tissue within each hole was cropped from digital
images using Northern Eclipse calibrated software to obtain total
area (TA, mm2) by training the threshold on all colours, then the
thresholds adjusted to total pink and red-stained area (TS), using
thresholds for Col-II Hue[30; 205] and Saturation[35; 255]; for Col-I
Hue[0; 220] and Saturation[30; 255] and for SafO Hue[20; 210] and
Saturation[50; 255]. Percent stained areawas obtained according to
% stain ¼ (TS)/TA (%)25. Hole depth was quantiﬁed in Gomori-
stained sections, using calibrated line measures in the middle of
the hole that spanned from the surface of the granulation tissue to
new bone at the base of the defect.
Fig. 2. Stereological analysis of BVs. Depth measurements and image acquisition within the drill hole tissue (A) for the Top-Down method (red) and the Bottom-Up method (blue);
BV quantiﬁcation in an example 40 magniﬁcation digital image showing measures of (B) the number of BV cross-sections (QBV) to calculate LV (black arrows; forbidden lines and
excluded BV in red), (C) the grid intersections (points) contained in BV (white dots, PBV) to calculate VV and also used as the reference volume to calculate SV by Grifﬁth’s method,
and (D) the number of intersections between the test lines and the BV wall (black crosses, IBV) to calculate both Castello’s and Grifﬁth’s SV.
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A repeated measures Analysis of the Variance (ANOVA) model
was used to evaluate the effect of treatment condition on depth-
wise angiogenesis and matrix deposition. The computations were
donewith the Statistica software version 10 (Statsoft Inc., Tulsa, OK,
USA). Knees in different treatment conditions came from different
rabbits (Table I). Therefore the knees were deﬁned as the statistical
units26. The response variables LV, VV, SVC and SVG were analysed
using three factors: treatment condition, drill hole, depth level.
Treatment condition is a between factor, set at ﬁve levels (drill-
only; implant-only, implant with rhFVIIa, implant with TFþrhFVIIa,
implant with IIa, N ¼ 4 or N ¼ 6). The other two factors are within
factors: holes at two levels (medial, lateral), depth level at three
levels (0, 0.5, and 1.0 mm from the reference line). To evaluate the
effects of the three factors on each of the response variables, a
repeated measures analysis of variance model was used. Factors
treatment condition and hole were not signiﬁcant, but depth was
signiﬁcant. To investigate why the clearly angiogenic implant-
treated holes were not giving signiﬁcantly higher BV features, we
performed a second ANOVA, to test the hypothesis that residual
chitosan implant suppresses angiogenesis locally. Because implant
deposits were found to occur at discrete levels in the holes (mainly
at the top), and some histology ﬁelds in a given hole overlapped
with residual implant and others did not, we performed these an-
alyses using histology ﬁeld as the statistical unit, with VV measures
at three depths (0, 0.5, 1.0 from the surface) and two conditions
(residual implant: yes/no) as between-effect factors, to observe the
effect of residual implant, in treated defects-only. Differences in VV
were also analysed for histology ﬁelds taken at three depths from
the surface (0, 0.5, 1.0) for only those implant-treated drill holes
completely cleared of chitosan particles vs drill-only as the twoconditions.We also analysed themean LV, VV, SV (up to 1.5 mm from
the surface), the soft tissue % stain (Col-I, Col-II, SafO), the hole
cross-sectional area and the residual hole depth, and using
repeated analysis of variance model with treatment condition as a
between factor and hole as the repeated measure. All analyses were
completed with a post-hoc Tukey HSD test to analyse differences.
The study design assumes that the observed outcomes are inde-
pendent of animal, knee (left-right), age, and sex (male-female).
The usual assumptions of a repeated measure analysis of variance
model: constancy of variance, normality of residuals, Mauchley
Sphericity test of compound symmetry (intraclass coefﬁcient) were
all checked and proved to be satisﬁed. A P-value of 0.05 or smaller
was considered statistically signiﬁcant. Conﬁdence intervals were
also computed.
Results
Macroscopic observations of knees and microdrilled cartilage defect
appearance
Marrow stimulation surgery and arthrotomy, with or without
implant, elicited sterile inﬂammation as shown by soft tissue par-
apatellar swelling at 1 week post-operative in roughly half the
operated knees, that persisted in 30% of drill-only, and 50% of
implant-treated knees (coagulation factors) at 21 days post-
operative, without signs of infection. At necropsy, almost all con-
trol drill holes were ﬁlled with a white repair tissue while most
treated drill holes were ﬁlled with either a red or dull white-grey
repair tissue. The macroscopic “reddish” appearance coincided
with the presence of large BVs at the base of the hole in the his-
tology sections, while white repair tissues had abundant extracel-
lular matrix at the top of the hole (Fig. 3).
Fig. 3. Macroscopic defect appearance and corresponding microscopic features. Image at necropsy of the cartilage defect in a representative control sample (drill-only, AeE) and a
treated sample (chitosan implant with rhFVIIa, FeJ) and the corresponding histology of the two distal holes (Gomori trichrome stain, SafraninO/Fast Green stain; or pink collagen
immunostain as indicated). Big BVs (red arrows) and low collagen seen on the histologic sections give the reddish colour to the repair tissue at necropsy.
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Top-down stereology measures revealed a strong depth-
dependent increase in angiogenic vessels in all healing drill holes,
for all BV features, LV, VV, SVC and SVG [P < 0.005, Fig. 4(A1-D1)]. At
1 mm deep in the hole, soft tissues containedw60 to 120 BV/mm2
that occupied 8e24% of the tissue volume [LV, VV, Fig. 4(A1eB1)].
Towards the surface of the hole, BVs were smaller, and provided a
lower surface area [P < 0.005, SVG, SVC, Fig. 4(C1eD1)]. Altogether,
these data illustrate clearly the anisotropic BV growth in the
microdrilled hole from the base of the hole towards the surface and
indicate the location of larger vessels deeper in the holes. Coagu-
lation factors approximately doubled VV and SVC at 0.5 mm deep vs
controls, but the effect was not signiﬁcant with N ¼ 4 vs N ¼ 6
The Bottom-up method produced more variation in the data for
each condition, compared to the Top-downmethod [Fig. 4(A2eD2)].
These measures slightly farther down in the hole showed a depth-
dependent increase for VV, SVC and SVG [P < 0.05, Fig. 4(B2eD2)],
but not for LV. The analysis also revealed a signiﬁcant interaction of
treatment condition and depth, for VV, SVC and SVG (P ¼ 0.040,
P¼ 0.049, P¼ 0.010, respectively), related to bigger BVs in implant-
treated vs drill-only repair tissues, formeasures collected at 0.6mm
from the base of the drill hole [Fig. 4(B2eD2)]. Vessels elicited by
implant allow a higher blood inﬂow in the granulation tissue in
comparison to microdrilling-alone.
The mean Top-down stereology measures showed a similar LV
(w70/mm2) for all treatment conditions [Fig. 5(A)]. Compared to
drill-only, coagulation factor implants elicited w3-fold higher
mean VV, a higher surface area (i.e., branching, SVC), and w30%
lower surface-to-volume ratio (i.e., bigger vessels, SVG), [Fig. 5(Be
D)]. These data agreed with macroscopic evidence of angiogenesis
[Fig. 2(A)], but the differences were not signiﬁcant.
In closer inspection of the histology, we noticed that some
implant-treated drill holes contained focal areas with residual
chitosan particles ﬂanked by neutrophils, and few BVs. Stratifying
VV measures for residual chitosan particles revealed that residual
implant signiﬁcantly suppressed angiogenesis locally [P ¼ 0.027,
Fig. 6(A)]. Treated drill holes completely cleared of chitosan parti-
cles had a signiﬁcantly higher BV volume compared to drill-only
holes, particularly at 1 mm deep [P ¼ 0.049, Fig. 6(B)].Chitosan implant delays collagen type II and GAG deposition in
healing drill holes
All bone defects were healing, as the average soft tissue areawas
smaller than the initial defect area (w3.6 mm2) and shallower than
the initial depth (w3e4 mm) [Fig. 7(A)]. The average hole depth
ranged from w1.7 to 2.0 mm (drill-only, rhFVIIa-implant,
TFþrhFVIIa-implant), 2.3 mm (implant), and 2.6 mm [IIa-implant,
Fig. 7(A)]. IIa-implant-treated drill holes had the largest cross-
sectional area and deepest holes, of all treatment groups
[Fig. 7(A)]. These data were consistent with a previous report that
IIa-chitosan implant induces transient osteoclast activity at the
edges of the drill hole27.
In all defects treated with chitosan implant, only traces of GAG
and Col-II were found, whereas defects that were only microdrilled
had about 20% of the tissue area on the histological sections stained
positively for both GAG and Col-II [P < 0.005 and P < 0.0005
respectively drill-only vs all implant conditions, Fig. 7(BeC)]. For
Col-I deposition, the mean percent Col-I for the drill-only group
was about twice higher than the other treatment conditions, and
the addition of coagulation factors to the implant did not alter these
results [Fig. 7(D)]. GAG and Col-II mixed with Col-I consist of
ﬁbrocartilage, therefore ﬁbrocartilage formationwas suppressed by
the use of chitosan implant irrespective of the addition of coagu-
lation factor. Accumulation of Col-I and Col-II in the matrix of
control holes around 0.5 mm from the surface was mutually
exclusive of BV growth in this area (Fig. 8). In addition, the lack of
bone plate remodeling in control defects and poor lateral integra-
tion of ﬁbrocartilage with the bone plate seems to prevent
ingrowth of vessels from trabeculae at the bone plate level. The
collective data in this study are consistent with a model where
smaller BV form less frequently at the surface of the repair tissue,
due to build-up of ﬁbrocartilage and lack of bone plate integration
(drill-only), or to residual implant near the surface of the defect,
whose clearance ampliﬁes the angiogenic response (schematic,
Fig. 9).
Discussion
This study reports the novel ﬁnding of spatial guidance of BVs
towards the surface of repairing microdrill holes in a model of bone
marrow stimulation-based articular cartilage repair. Prior analyses
Fig. 4. Depth-dependent angiogenesis in repairing microdrill holes at 3 weeks post-operative with and without implant and coagulation factors. Two stereological approaches were
used to analyse four BV stereology features: Top-down (A1-D1) and Bottom-up (A2-D2), for LV (A), VV (B), SVC (C) and SVG (D). Data are shown as the mean (marker), with the
uncertainty estimated by standard error (S.E., box) and 95% conﬁdence intervals (C.I., whisker). P-values for depth, or signiﬁcant effects of depth*condition are shown at the top of
each panel. Abbreviations: Drl (drill-only); Imp (implant-only) and implant with coagulation factors, rhFVIIa, TFþrhFVIIa, or IIa (as shown); SVC: Castello’s SV. SVG: Grifﬁth’s SV.
Symbols: x (panel D.1) indicates that none of the histology images at the top of drill hole (0 mm) in drill-only defects had BVs and therefore there are no data for SVG at 0 mm, drill-
only. Only ﬁelds containing BVs were used to calculate Grifﬁth’s SV and no value was attributed to ﬁelds without any BVs.
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conﬁned to qualitative observations or cross-sections of BVs in a
selected area28,29,30, which fall short of demonstrating spatial or
volume-dependent changes in angiogenesis. In this study, depth-
wise stereological measures revealed that the chitosan-GP/blood
implant promotes the formation of larger BVs in healing micro-
drill holes [Fig. 4], particularly after residual chitosan particles arecleared [Fig. 6(B)]. The Top-down method is both quantitative and
reproducible, since the average LV results obtained are in the same
range as those obtained in a similar model at 21 days post-surgery8.
BV stereology standardizes the data, which permits direct com-
parison of the data to other studies.
BV VV can vary from 3% (brain tissues), 7% (nasal mucosa) to 29%
(placenta)21,31,32. Therefore, the 20% VV elicited by chitosan implant
Fig. 5.. Mean BV stereology features Lv (A), VV (B), SVC (C) and SVG (D) in repairing microdrill holes from the surface to 1.5 mm deep in the hole (Top-down approach). No signiﬁcant
differences were found between conditions using a repeated measures ANOVA and Tukey HSD post-hoc analysis (N ¼ 4 or N ¼ 6). Data are shown as the mean (marker) with the
uncertainty estimated by S.E. (box) and 95% C.I. (whisker). Abbreviations: Drl (drill-only); Imp (implant-only) and implant with coagulation factors, rhFVIIa, TFþrhFVIIa, or IIa (as
shown); SVC: Castello’s Sv. SvG: Grifﬁth’s SV.
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angiogenic response [Figs. 4(B) & 6]. Thrombin peptide TP508 and
thrombin were previously shown to stimulate angiogenesis in
subcutaneous sites, and TP508 stimulated the formation of large
vessels in repairing bone fracture callus, but the actual vessel di-
mensions were not reported33,34. Due to low sample numbers used
in this study, speciﬁc effects of coagulation factor on drill hole
angiogenesis could not be demonstrated, although IIa-implant
treated defects were found to have the largest vessels, biggest
drill hole area, and less residual chitosan implant at 3 weeks post-
operative.
In other cartilage repair studies, chitosan has been designed as a
scaffold to promote chondrocyte cell adhesion, or as a carrier for
chondrogenic factors35e38. However, it may be unrealistic to expect
that chitosan can persist in vivo and also deliver a cargo to newFig. 6. Residual chitosan delays, and chitosan clearance ampliﬁes, BV ingrowth into repair
individual histology ﬁelds signiﬁcantly delay local ingrowth of BVs (represented by VV). Pan
versus drill-only control defects. Data are shown as the mean (marker) with the uncertaintchondrocytes, given that subchondral chitosan delays angiogenesis
(Fig. 6) and chondrogenesis (Fig. 8)39 and also given that prolonged
chitosan residency can block cartilage repair40. Improved control
over chitosan localization, amount delivered, and the rate of
clearance from cartilage repair sites that connect with bone
marrow remain important challenges for future work.
Among the four stereology parameters analysed, VV best
revealed differences due to treatment condition, perhaps in part
due to the unbiased nature of point-counting. Stereology theoret-
ically assumes an isotropic structure, and uses random sampling
techniques to reduce bias19e22, but in the case of cartilage repair,
the biological processes of interest occur in an anisotropic granu-
lation tissue therefore traditional sampling techniques cannot be
applied. LV and SV parameters were partially biased by the aniso-
tropic orientation of BV growth from the vascular bone perimeter toing subchondral drill holes. Panel A shows that residual chitosan particles present in
el B shows that VV is signiﬁcantly higher in drill holes completely cleared of chitosan
y estimated by S.E. (box) and 95% C.I. (whisker).
Fig. 7. Extracellular matrix deposition in repairing microdrill holes at 21 days post-operative. Chitosan implant suppressed collagen type II and GAG deposition, and diminished
collagen type I levels, and coagulation factors had no inﬂuence. (A) Hole depth and cross-sectional area. Mean Col-II (B) and GAG (C) were signiﬁcantly lower in each implant-treated
condition compared to drill-only. Mean Col-1 levels (D) were lower in treated defects. Data are shown as the mean (marker), with the uncertainty estimated by S.E. (box) and 95%
C.I. (whiskers). Symbols: Horizontal arrows in Panel A indicate the approximate initial defect depth and cross-sectional area.
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further reduce bias in SV measures. We also collected measures in
the middle of the holes to minimize bias due to slight variations in
drill hole angle and sectioning plane. Other limitations in the
methodology were inherent to the wide variation in BV size. Small
capillaries were not visible at lower magniﬁcations, which obliged
us to use 40magniﬁcation images, and very large vessels crossed
the forbidden lines in some 40 magniﬁcation images, generating
Lv ¼ 0 and high VV for eight out of 166 measures, which has a very
low impact on the averaged data. Discrete 40 images sometimes
missed the largest BVs. Castello’s and Grifﬁth’s SV methods provide
distinct information on angiogenic vessels: higher SVC valuesFig. 8. BV localisation and collagen type I and type II deposition. Histological images at the
B,D,F,H,J,L) in a representative control sample (drill-only) and a treated sample (chitosan i
tochemistry (Collagen type I and type II) stains. BVs are seen in regions with little collagen de
(AeF, treated) or below the foci (GeL, control).suggest branching, while lower SVG values indicate a lower surface-
volume ratio thus bigger BVs and more tissue oxygenation in the
chosen reference volume. Future studies may ﬁndmore differences
in subchondral angiogenesis through VV and SVC or SVG, rather
than LV.
Fibrocartilage is a type of scar tissue found in non-union long
bone fractures that resists remodeling and does not naturally
proceed to hypertrophy and vascular invasion41. In large osteo-
chondral drill holes in young rabbit knees, rapid angiogenesis at 1
week post-operativewas previously found by Furokawa et al (1980)
to elicit abundant collagen deposition in the drill hole at 3 weeks
(w30% per dry weight collagen, and around twice as much Col-I assurface of the soft repair tissue (10, A,C,E,G,I,K) and at 0.4 mm from the surface (20x,
mplant with factor rhFVIIa) with histochemistry (Gomori trichrome) and immunohis-
position, whether it is type I or type II, and occurred either above the chondrogenic foci
Fig. 9. Schematic depicting angiogenesis into healing microdrill holes without and with chitosan-GP/blood implant treatment, and corresponding averaged BV stereology pa-
rameters for the drill holes in the three conditions: Drill holes from drill-only defects (N ¼ 12), implant-treated drill holes with residual chitosan deposits (N ¼ 14), and implant-
treated drill holes completely cleared of implant (N ¼ 22). Stereology parameters were averaged from three histology ﬁelds acquired at the surface, 0.5 mm and 1.0 mm deep in the
hole.
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implant is highly reproducible8,9,12 (Fig. 7), and partly explains the
macroscopic red hue of the granulation tissue in the absence of
collagen accumulation. Suppression of ﬁbrocartilage could be
considered a therapeutic response that permits other repair pro-
cesses to take place. Suppression of Col-II accompanied by large BVs
occurred more frequently, when initial chitosan residency18,43, was
followed by rapid chitosan clearance (Fig. 6). Thrombin is chemo-
tactic for neutrophils44, which degrade chitosan. Thrombin and
FVIIa also activate protease-activated receptors PAR1 and PAR2,
respectively45, which are found in platelets, bone lineage precursor
cells and stromal cells (reviewed in46). Bone remodeling, which is
enhanced by chitosan27, especially at the bone plate level39,43,47
(Fig. 8) also favours angiogenesis into the drill hole. Diffusion of
angiogenic factors from the synovial cavity could also partly explain
the anisotropic, depth-dependent BV LV, VV and SV.
Because IIa-chitosan-GP/blood implant elicits a more hyaline
repair tissue in microdrilled defects compared to surgical controls
at later repair periods27,48, higher subchondral angiogenesis at 3
weeks post-operative due to IIa could be an indicator of better
cartilage repair. But in a cortical fracture-repair model, higher
thrombin dosages stimulated too much angiogenesis and remod-
eling45. In this study, only a few coagulation factors, currently used
in clinical applications49e51, have been tested and at only one or
two concentrations. It seems obvious that angiogenesis is necessary
in microfracture and bone fracture repair52, if only to provide nu-
trients and gas exchange in the repairing tissue; but many factors
inﬂuence angiogenesis45, through mechanisms that are not yet
completely understood. Thus, it is necessary to improve our
knowledge of angiogenesis to be able to determine when it works
in favour of microfracture-based cartilage repair or when it can be
harmful. It is difﬁcult to anticipate the appropriate biological factor
and dosage that could be applied to an acute, bleeding defect, to
stimulate an adequate cartilage repair, without the full under-
standing of the cross-talk between the various cellular and mo-
lecular players of tissue repair and angiogenesis2. This study shows
that puriﬁed thrombin has the potential to exert beneﬁcial effectsat doses sufﬁcient to promote rapid in situ clotting of the hybrid
clot18. For future studies it will be important to determine when
BVs should optimally regress, to restore the subchondral bone,
articular cartilage, and the tidemark.Role of the authors
The authors made substantial contributions in designing the study
(CDH, GER), gathering and analysing the data (CM, AC, VL, CDH) and
drafting (CM, CDH) and revising the article (CM, AC, GER, CDH).
Data in this paper were collected towards the M.Sc. thesis of CM.Role of the funding source
Operating grants from CIHR and NSERC paid for all experimental
procedures, graduate student stipends, salary support for
research staff, and towards presentation of the ﬁndings at the
Canadian Connective Tissue Conference (May 2011, Montreal, QC,
Canada), the Cell Science and Stem Cell Research Conference
(Sept 2011, Philadelphia, PA, USA) and the International Cartilage
Repair Society World Congress (May 2012, Montreal, QC, Canada).
FRQ-S GRSTB funds provided partial salary support for research
staff.Conﬂict of Interest Statement
The authors have no competing interests to declare.Acknowledgements
Support: Canadian Institutes of Health Research (Grant No.
BME-185810), Natural Science and Engineering Council of Canada
(Discovery Grant No. 262874), the Fonds de la Recherche en Santé
du Québec (FRQ-S) Groupe de Recherche en Sciences et Technolo-
gies Biomédicales (GRSTB), and salary support from the FRQ-S
(Bourse de Carrière Chercheur National, CDH). We gratefully
acknowledge Hugo Boulanger and Gaoping Chen for valuable
technical contributions, and Julie Tremblay for Quality Assurance.
C. Mathieu et al. / Osteoarthritis and Cartilage 21 (2013) 849e859858References
1. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound
repair and regeneration. Nature 2008;453:314e21.
2. Eming SA, Krieg T, Davidson JM. Inﬂammation in wound
repair: molecular and cellular mechanisms. J Invest Dermatol
2007;127:514e25.
3. Insall JN. Intra-articular surgery for degenerative arthritis of
the knee. A report of the work of the late K. H. Pridie. J Bone
Joint Surgery-Br Vol 1967;49:211e28.
4. Meachim G, Roberts C. Repair of the joint surface from sub-
articular tissue in the rabbit knee. J Anat 1971;109:317e27.
5. Steadman JR, Rodkey WG, Briggs KK. Microfracture Cartilage
2010;1:78e86.
6. Hoemann CD, Hurtig M, Rossomacha E, Sun J, Chevrier A,
Shive MS, et al. Chitosan-glycerol phosphate/blood implants
improve hyaline cartilage repair in ovine microfracture de-
fects. J Bone Joint Surg Am 2005;87:2671e86.
7. Hoemann CD, Sun J, Mckee MD, Chevrier A, Rossomacha E,
Rivard GE, et al. Chitosan-glycerol phosphate/blood implants
elicit hyaline cartilage repair integrated with porous sub-
chondral bone in microdrilled rabbit defects. Osteoarthritis
Cartilage 2007;15:78e89.
8. Chevrier A, Hoemann CD, Sun J, Buschmann MD. Chitosan-glyc-
erol phosphate/blood implants increase cell recruitment, tran-
sient vascularization and subchondral bone remodeling indrilled
cartilage defects. Osteoarthritis Cartilage 2007;15:316e27.
9. Hoemann CD, Chen G, Marchand C, Tran-Khanh N, Thibault M,
Chevrier A, et al. Scaffold-guided subchondral bone repair:
implication of neutrophils and alternatively activated
arginase-1þ macrophages. Am J Sports Med 2010;38:1845e
56.
10. Jain RK. Molecular regulation of vessel maturation. Nat Med
2003;9:685e93.
11. Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R,
Clementi E, et al. Inﬂammatory and alternatively activated
human macrophages attract vessel-associated stem cells,
relying on separate HMGB1- and MMP-9-dependent path-
ways. J Leukoc Biol 2009;85:779e87.
12. Chevrier A, Hoemann CD, Sun J, Buschmann MD. Temporal and
spatial modulation of chondrogenic foci in subchondral
microdrill holes by chitosan-glycerol phosphate/blood im-
plants. Osteoarthritis Cartilage 2011;19:136e44.
13. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation
in the repair of full-thickness defects of articular cartilage.
J Bone Joint Surg Am 1993;75:532e53.
14. Kirilak Y, Pavlos NJ, Willers CR, Han R, Feng H, Xu J, et al. Fibrin
sealant promotes migration and proliferation of human artic-
ular chondrocytes: possible involvement of thrombin and
protease-activated receptors. Int J Mol Med 2006;17:551e8.
15. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mecha-
nism of thrombin-induced angiogenesis. Biochem Soc Trans
2002;30:173e7.
16. Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M,
Nikawa H, et al. Comprehensive analysis of chemotactic factors
for bone marrow mesenchymal stem cells. Stem Cells Dev
2007;16:119e29.
17. Fan L, Yotov WV, Zhu T, Esmailzadeh L, Joyal JS, Sennlaub F,
et al. Tissue factor enhances protease-activated receptor-2-
mediated factor VIIa cell proliferative properties. J Thromb
Haemost 2005;3:1056e63.
18. Marchand C, Rivard GE, Sun J, Hoemann CD. Solidiﬁcation
mechanisms of chitosan-glycerol phosphate/blood implant for
articular cartilage repair. Osteoarthritis Cartilage 2009;17:
953e60.19. Grifﬁths G, Burke B, Lucocq J. Fine Structure Immunocyto-
chemistry. Berlin; New York: Springer-Verlag; 1993.
20. Baddeley AJ. Monographs on Statistics and Applied Probabil-
ity: Stereology for Statisticians. Boca Raton, FL, USA: CRC Press;
2004.
21. Dockery P, Fraher J. The quantiﬁcation of vascular beds: a
stereological approach. Exp Mol Pathol 2007;82:110e20.
22. Garcia Y, Breen A, Burugapalli K, Dockery P, Pandit A. Stereo-
logical methods to assess tissue response for tissue-
engineered scaffolds. Biomaterials 2007;28:175e86.
23. Mathieu-Castello O. Stereology. In: Skalak R, Chien S, Eds.
Handbook of Bioengineering. New York: McGraw-Hill; 1987.
35.1e35.31.
24. Chevrier A, Rossomacha E, Buschmann MD, Hoemann CD.
Optimization of histoprocessing methods to detect glycos-
aminoglycan, collagen type II, and collagen type I in decalciﬁed
rabbit osteochondral sections. J Histotechnology 2005;28:
165e75.
25. Hoemann C, Kandel R, Roberts S, Saris DBF, Creemers L, Mainil-
Varlet P, et al. International Cartilage Repair Society (ICRS)
Recommended Guidelines for histological endpoints for
cartilage repair studies in animal models and clinical trials.
Cartilage 2011;2:153e72.
26. Ranstam J. Repeated measurements, bilateral observations and
pseudoreplicates, why does it matter? Osteoarthritis Cartilage
2012;20:473e5.
27. Chen G, Sun J, Lascau-Coman V, Chevrier A, Marchand C,
Hoemann CD. Acute osteoclast activity following subchondral
drilling is promoted by chitosan and associated with improved
cartilage repair tissue integration. Cartilage 2011;2:173e85.
28. Mapp PI, Avery PS, McWilliams DF, Bowyer J, Day C, Moores S,
et al. Angiogenesis in two animal models of osteoarthritis.
Osteoarthritis Cartilage 2008;16:61e9.
29. Wang L, Fan H, Zhang ZY, Lou AJ, Pei GX, Jiang S, et al.
Osteogenesis and angiogenesis of tissue-engineered bone
constructed by prevascularized beta-tricalcium phosphate
scaffold and mesenchymal stem cells. Biomaterials 2010;31:
9452e61.
30. Henno S, Lambotte JC, Glez D, Guigand M, Lancien G,
Cathelineau G. Characterisation and quantiﬁcation of angio-
genesis in beta-tricalcium phosphate implants by immuno-
histochemistry and transmission electron microscopy.
Biomaterials 2003;24:3173e81.
31. Abrams DC, Toynton SC, Dore C, Emson MA, Taylor P,
Springall DR, et al. Stereological estimation of blood vessel
surface and volume densities in human normal and rhinitic
nasal mucosa. Rhinology 1997;35:22e7.
32. Mayhew TM, Wijesekara J, Baker PN, Ong SS. Morphometric
evidence that villous development and fetoplacental angio-
genesis are compromised by intrauterine growth restriction
but not by pre-eclampsia. Placenta 2004;25:829e33.
33. Carney DH, Mann R, Redin WR, Pernia SD, Berry D, Heggers JP,
et al. Enhancement of incisional wound-healing and neo-
vascularization in normal rats by thrombin and synthetic
thrombin receptor-activating peptides. J Clin Invest 1992;89:
1469e77.
34. Wang HL, Li XM, Tomin E, Doty SB, Lane JM, Carney DH, et al.
Thrombin peptide (TP508) promotes fracture repair by up-
regulating inﬂammatory mediators, early growth factors, and
increasing angiogenesis. J Orthopaedic Res 2005;23:671e9.
35. Hasanova GI, Noriega SE, Mamedov TG, Thakurta SG,
Turner JA, Subramanian A. The effect of ultrasound stimula-
tion on the gene and protein expression of chondrocytes
seeded in chitosan scaffolds. J Tissue Eng Regen Med 2011;5:
815e22.
C. Mathieu et al. / Osteoarthritis and Cartilage 21 (2013) 849e859 85936. Li JJ, Zhao Q, Wang EB, Zhang CH, Wang GB, Yuan Q. Dynamic
compression of rabbit adipose-derived stem cells transfected
with insulin-like growth factor 1 in chitosan/gelatin scaffolds
induces chondrogenesis and matrix biosynthesis. J Cell Physiol
2012;227:2003e12.
37. Siu RK, Zara JN, Hou YP, James AW, Kwak J, Zhang XL, et al.
NELL-1 promotes cartilage regeneration in an in vivo rabbit
model. Tissue Eng Part A 2012;18:252e61.
38. Yang Z, Wu YN, Li C, Zhang TT, Zou Y, Hui JHP, et al. Improved
mesenchymal stem cells Attachment and in vitro cartilage
tissue formation on chitosan-modiﬁed poly(L-lactide-co-
epsilon-caprolactone) scaffold. Tissue Eng Part A 2012;18:
242e51.
39. Lafantaisie-Favreau CH, Guzman-Morales J, Sun J, Chen G,
Harris A, Smith TD, et al. Subchondral pre-solidiﬁed chitosan/
blood implants elicit reproducible early osteochondral wound-
repair responses including neutrophil and stromal cell
chemotaxis, bone resorption and repair, enhanced repair tis-
sue integration and delayed matrix deposition. BMC Muscu-
loskelet Disord 2013;14:27.
40. Abarrategi A, Lopiz-Morales Y, Ramos V, Civantos A, Lopez-
Duran L, Marco F, et al. Chitosan scaffolds for osteochondral
tissue regeneration. J Biomed Mater Res Part A 2010;95A:
1132e41.
41. Claes L, Recknagel S, Ignatius A. Fracture healing under healthy
and inﬂammatory conditions. Nat Rev Rheumatol 2012;8:
133e43.
42. Furukawa T, Eyre DR, Koide S, Glimcher MJ. Biochemical
studies on repair cartilage resurfacing experimental defects in
the rabbit knee. J Bone Joint Surg Am 1980;62:79e89.
43. Marchand C, Chen HM, Buschmann MD, Hoemann CD. Stan-
dardized three-dimensional volumes of interest with adapted
surfaces for more precise subchondral bone analyses by micro-
computed tomography. Tissue Eng Part C-Methods 2011;17:
475e84.44. Bizios R, Lai L, Fenton 2nd JW, Malik AB. Thrombin-induced
chemotaxis and aggregation of neutrophils. J Cell Physiol
1986;128:485e90.
45. Mackie EJ, Loh LH, Sivagurunathan S, Uaesoontrachoon K,
Yoo HJ, Wong D, et al. Protease-activated receptors in the
musculoskeletal system. Int J Biochem Cell Biol 2008;40:
1169e84.
46. Ossovskaya VS, Bunnett NW. Protease-activated receptors:
contribution to physiology and disease. Physiol Rev 2004;84:
579e621.
47. Hoemann CD, Lafantaisie-Favreau C-H, Lascau-Coman V,
Chen G, Guzmán-Morales J. The cartilage-bone interface.
J Knee Surg 2012;25:85e98.
48. Marchand C, Chen GP, Tran-Khanh N, Sun J, Chen HM,
Buschmann MD, et al. Microdrilled cartilage defects treated
with thrombin-solidiﬁed chitosan/blood implant regenerate a
more hyaline, stable, and structurally integrated osteochon-
dral unit compared to drilled controls. Tissue Eng Part A
2012;18:508e19.
49. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC.
Quantitation of activated factor VII levels in plasma using a
tissue factor mutant selectively deﬁcient in promoting factor
VII activation. Blood 1993;81:734e44.
50. Philippart P, Daubie V, Pochet R. Sinus grafting using recom-
binant human tissue factor, platelet-rich plasma gel, autolo-
gous bone, and anorganic bovine bone mineral xenograft:
histologic analysis and case reports. Int J Oral Maxillofac Im-
plants 2005;20:274e81.
51. Wilbourn B, Harrison P, Mackie IJ, Liesner R, Machin SJ. Acti-
vation of platelets in whole blood by recombinant factor VIIa
by a thrombin-dependent mechanism. Br J Haematol
2003;122:651e61.
52. Hankenson KD, Dishowitz M, Gray C, Schenker M. Angiogen-
esis in bone regeneration. Injury-Int J Care Injured 2011;42:
556e61.
